financetom
Business
financetom
/
Business
/
Costco's Premium Valuation Driven by Market Share Gains, Margin Improvements, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Costco's Premium Valuation Driven by Market Share Gains, Margin Improvements, UBS Says
Sep 27, 2024 12:12 PM

12:11 PM EDT, 09/27/2024 (MT Newswires) -- Costco Wholesale's ( COST ) premium valuation is partly due to its "continued market share gains" and consistent core margin improvements, UBS said in a note Friday.

"These factors have driven a substantial improvement in Costco's Return on Incremental Invested Capital ("ROIIC") over the last several years," UBS said. Costco's ROIIC increased by approximately 50% since 2019, the firm added.

Costco Wholesale ( COST ) reported fiscal Q4 earnings beat late Thursday of $5.29 per diluted share, against analyst expectations of $5.06. Costco reported another strong quarter, achieving significant market share gains with worldwide traffic up 6.4% year-over-year and US traffic rising 5.6%, UBS said.

"During the fourth quarter, it continued to generate gains across its P&L while it still invested for the future. Thus, we think the shares should continue to trade at a premium multiple and its stock can be driven by further earnings gains," UBS said.

UBS maintained a buy rating on Costco's stock with a $940 price target.

Costco shares fell 1.8% in recent trading.

Price: 885.18, Change: -16.26, Percent Change: -1.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Regenxbio's Duchenne gene therapy shows improved muscle function in trial
Regenxbio's Duchenne gene therapy shows improved muscle function in trial
Mar 11, 2026
March 11 (Reuters) - Regenxbio ( RGNX ) said on Wednesday that an interim data from a early-to-mid stage study of its experimental gene therapy in patients with Duchenne muscular dystrophy showed continued improvement in muscle function and a clean safety profile. (Reporting by Kamal Choudhury in Bengaluru) ...
Provident Healthcare Partners Advises A Caring Experience Nursing Services, Inc. on its Acquisition by HouseWorks Holdings, LLC, a Portfolio Company of InTandem Capital Partners
Provident Healthcare Partners Advises A Caring Experience Nursing Services, Inc. on its Acquisition by HouseWorks Holdings, LLC, a Portfolio Company of InTandem Capital Partners
Mar 11, 2026
BOSTON, March 11, 2026 /PRNewswire/ -- Provident Healthcare Partners (Provident), a leading healthcare investment banking firm, announced it has advised A Caring Experience Nursing Services, Inc. (ACE), a Cranston, Rhode Island-based provider of in-home care services, on its partnership with HouseWorks Holdings, LLC (HouseWorks), one of the nation's leading personal care services companies. The acquisition expands HouseWorks' footprint in New...
Navitas Semiconductor Stock Soars After New Product Launch
Navitas Semiconductor Stock Soars After New Product Launch
Mar 11, 2026
Navitas Semiconductor Corp ( NVTS ) shares are trading higher Wednesday morning after the company unveiled two new additions to its 5th generation GeneSiC silicon carbide power semiconductor platform, highlighting its push into AI data centers and energy infrastructure. Here’s what investors need to know. Navitas Semiconductor ( NVTS ) stock is among today’s top performers. What’s fueling NVTS momentum?...
US DOJ says Aetna to pay $117.7 million to resolve False Claims Act allegations
US DOJ says Aetna to pay $117.7 million to resolve False Claims Act allegations
Mar 11, 2026
WASHINGTON, March 11 (Reuters) - The U.S. Justice Department said on Wednesday that CVS Health's ( CVS ) Aetna agreed to pay $117.7 million to resolve allegations that it violated the False Claims Act. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved